Verde Bio HOLDINGS, Inc. (APHD) intrinsic value & 10-year financials
Verde Bio HOLDINGS, Inc. (APHD) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.27
- Market cap
- $1.9M
- Revenue (FY2023)
- —
- Revenue growth (10-yr CAGR)
- 47.9%
- ROIC (10-yr avg)
- 43.7%
- Free cash flow (FY2023)
- -$879.2K
APHD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2023 | — | -$1.9M | — | -$879.2K | — | -58.0% |
| FY2022 | — | -$3.4M | — | -$4.0M | — | -153.0% |
| FY2021 | — | -$3.3M | — | — | — | 238.2% |
| FY2020 | — | -$1.6M | -$1.03 | — | — | 8.3% |
| FY2019 | $0 | -$537.1K | -$0.53 | — | — | 2.1% |
| FY2018 | $41.9K | -$1.5M | — | — | -1077.2% | 27.8% |
| FY2017 | $50.3K | -$2.3M | — | — | -906.7% | 41.6% |
| FY2016 | $904 | -$125.6K | — | — | -21715.4% | 36.9% |
| FY2015 | $258 | -$797.9K | — | — | -90510.1% | 54.6% |
| FY2014 | $8.7K | -$868.0K | — | -$241.8K | -7336.6% | 238.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
VERDE BIO HOLDINGS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
VERDE BIO HOLDINGS, INC. returns on capital have been average, hovering around 11.6% ROIC over the decade.
VERDE BIO HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, VERDE BIO HOLDINGS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-40.46 per share.